The Microbiotics Company
Research and development
We understand bacteria
As a research and development company, Belano medical AG is a technological leader in the field of modern microbiotic products and positively acting bacteria.
Starting with probiotically acting lactic acid bacteria, we have identified and characterized specific strains and active ingredients in intensive research work. Today, these are industrially produced and individually formulated and can already be found on the market as finished products.
Our patented microbiotic active ingredients from lactic acid bacteria (Lactobacillus) work in two ways:
- some support the desirable “good” microorganisms - for example, those found on our skin - so that they’re not overgrown by pathogens, the former also displacing the latter from our skin.
- others act directly against pathogens such as streptococci, staphylococci, or helicobacter and prevent them from settling on the skin or in the body.
We research microbiomes and their effects on our health
Billions of bacteria in and on us help us to stay healthy. Knowledge about these tiny “roommates” has grown considerably in recent years. One finding is that we need a balanced and high diversity of microbiomes to fend off germs and to keep our immune system active and strong on our skin and in our intestines.
Dysbiosis, i.e. a shift in the natural balance, is associated with disorders and diseases. For example, when skin suffers from atopic dermatitis, it is overwhelmed with the inflammatory bacterium Staphylococcus aureus, which only occurs sporadically on healthy skin. Signs of colds are often accompanied by an increase in the bacterium Streptococcus pyogenes and stomach problems are often caused by the bacterium Helicobacter pylori.
We have researched these interactions between healthy microbiomes and pathogenic germs, developing “antagonists” and evaluating them in preclinical and clinical studies.
By using microbial antagonists and the gentle and efficient removal of the inflammatory germs, we were able to restore the natural balance in these ecosystems and, as a result, develop a new microbial therapy platform!
We develop clinically proven solutions
Our research department constantly analyzes microbiome interactions and further develops our products and active ingredients in our own laboratories (S2). Effect spectra are also carried out on behalf of customers. Clinical studies and approval processes are planned and executed with partners.
Our development department implements industrial production with European partners and also offers the development of customer-specific formulations.
Our active ingredients are patent-protected.
